- Home
- CAR vs ZLAB Comparison
CAR vs ZLAB Comparison
Compare CAR & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAR
- ZLAB
- Stock Information
- Founded
- CAR 1946
- ZLAB 2013
- Country
- CAR United States
- ZLAB China
- Employees
- CAR N/A
- ZLAB N/A
- Industry
- CAR Rental/Leasing Companies
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- CAR Consumer Discretionary
- ZLAB Health Care
- Exchange
- CAR Nasdaq
- ZLAB Nasdaq
- Market Cap
- CAR 3.1B
- ZLAB 3.0B
- IPO Year
- CAR N/A
- ZLAB 2017
- Fundamental
- Price
- CAR $101.29
- ZLAB $27.38
- Analyst Decision
- CAR Buy
- ZLAB Strong Buy
- Analyst Count
- CAR 8
- ZLAB 4
- Target Price
- CAR $133.13
- ZLAB $52.50
- AVG Volume (30 Days)
- CAR 854.4K
- ZLAB 1.2M
- Earning Date
- CAR 10-31-2024
- ZLAB 11-12-2024
- Dividend Yield
- CAR N/A
- ZLAB N/A
- EPS Growth
- CAR N/A
- ZLAB N/A
- EPS
- CAR 11.08
- ZLAB N/A
- Revenue
- CAR $11,843,000,000.00
- ZLAB $355,748,000.00
- Revenue This Year
- CAR N/A
- ZLAB $48.50
- Revenue Next Year
- CAR $1.58
- ZLAB $47.37
- P/E Ratio
- CAR $9.05
- ZLAB N/A
- Revenue Growth
- CAR N/A
- ZLAB 35.01
- 52 Week Low
- CAR $65.73
- ZLAB $13.48
- 52 Week High
- CAR $204.77
- ZLAB $36.60
- Technical
- Relative Strength Index (RSI)
- CAR 70.17
- ZLAB 49.37
- Support Level
- CAR $89.04
- ZLAB $26.47
- Resistance Level
- CAR $109.80
- ZLAB $32.15
- Average True Range (ATR)
- CAR 5.56
- ZLAB 1.36
- MACD
- CAR 1.94
- ZLAB -0.64
- Stochastic Oscillator
- CAR 86.22
- ZLAB 30.81
About CAR Avis Budget Group Inc.
Avis Budget Group Inc is a provider of automotive vehicle rental and car-sharing services. Its brands include Avis, Budget, and Zipcar. Avis is targeted to serve the premium commercial and leisure segments of the travel industry, while Budget is focused on value-conscious customers. The company operates its own network of rental locations and licenses its brands to franchisees. Zipcar is a car-sharing service that allows members to use the company-owned Zipcar fleet at an hourly rate. The company's largest region by revenue is the Americas.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.